Company
1.
About Us
"Introduction to HeimBiotek"
Advancing the Future of
Molecular Diagnostics
To uphold its commitment to excellence embodied in its motto to be “The First or The Best”, HeimBiotek Inc. has pioneered proprietary detection and analysis technology for microRNA, a small non-coding RNA, that is gaining recognition as a Next-Gen Diagnostic Tool. This state-of-the-art technology is being applied to develop diagnostic technology for disease detection utilizing circulating microRNA. We aim to harness this technology to develop liquid biopsy diagnostic kits, poised to revolutionize the future of molecular diagnostics.
Recently, the development of a liquid biopsy diagnostic kit for hepatocellular carcinoma has been completed successfully. Looking ahead, we aspire to introduce a Multi-Cancer Early Detection product capable of detecting 35 cancers simultaneously. In addition, steps are being taken to develop innovative PCR technology with high accuracy and sensitivity to establish a pipeline of products that address the unmet needs in the field of molecular diagnostics.
HeimBiotek Inc. aims to be a premier provider of molecular diagnostic technology for cancer diagnostics. Our mission is to establish ourselves as a global leader in the field of cancer diagnostics through continued R&D and commercialization efforts. We are dedicated to improving global health and enhancing the quality of life for all.
CEO J.H. Lee
2.
Our History
"The Path of Achievements"
Company History
Tech & Products History
Goverment R&D Program History
